GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
2.300
-0.170 (-6.88%)
Sep 21, 2026, 4:00 PM EDT - Market closed
GlucoTrack Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.12 | 7.38 | 5.62 | 4.49 | 2.31 | 6.06 |
Cash & Short-Term Investments | 1.12 | 7.38 | 5.62 | 4.49 | 2.31 | 6.06 |
Cash Growth | -88.24% | 31.44% | 25.05% | 94.29% | -61.86% | -38.29% |
Other Current Assets | 0.26 | 0.28 | 0.15 | 0.38 | 0.07 | 0.04 |
Total Current Assets | 1.38 | 7.67 | 5.77 | 4.87 | 2.38 | 6.11 |
Property, Plant & Equipment | 0.11 | 0.17 | 0.15 | 0.03 | 0.04 | 0.11 |
Other Long-Term Assets | - | - | 0.01 | 0.01 | 0.02 | 0.05 |
Total Assets | 1.5 | 7.84 | 5.93 | 4.91 | 2.44 | 6.27 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.12 | 1.32 | 0.99 | 0.84 | 0.67 | 0.63 |
Accrued Expenses | - | - | - | - | - | 0.23 |
Short-Term Debt | 1.69 | 3.18 | 0.01 | - | - | - |
Current Portion of Leases | 0.02 | 0.03 | 0.03 | - | - | 0.02 |
Other Current Liabilities | 0.16 | 0.25 | 0.25 | 0.67 | 0.34 | - |
Total Current Liabilities | 2.99 | 4.77 | 1.28 | 1.51 | 1.01 | 0.88 |
Long-Term Debt | 0.25 | 0.23 | 0.2 | 0.2 | 0.2 | 0.21 |
Long-Term Leases | - | 0.01 | 0.03 | - | - | 0.02 |
Other Long-Term Liabilities | - | 0 | 17.42 | - | - | - |
Total Liabilities | 3.24 | 5.01 | 18.93 | 1.71 | 1.21 | 1.11 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | - | 0.02 | 0.02 |
Additional Paid-In Capital | 158.19 | 151.08 | 119.23 | 112.99 | 103.1 | 102.61 |
Retained Earnings | -159.99 | -151.84 | -132.45 | -109.85 | -101.9 | -97.47 |
Comprehensive Income & Other | 0.05 | 3.59 | 0.22 | 0.06 | 0.02 | -0.01 |
Total Common Equity | -1.74 | 2.83 | -13 | 3.2 | 1.23 | 5.16 |
Shareholders' Equity | -1.74 | 2.83 | -13 | 3.2 | 1.23 | 5.16 |
Total Liabilities & Equity | 1.5 | 7.84 | 5.93 | 4.91 | 2.44 | 6.27 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.96 | 3.45 | 0.27 | 0.2 | 0.2 | 0.25 |
Net Cash (Debt) | -0.84 | 3.94 | 5.35 | 4.3 | 2.12 | 5.81 |
Net Cash Growth | - | -26.41% | 24.53% | 102.93% | -63.58% | -38.56% |
Net Cash Per Share | -5.90 | 95.08 | - | - | - | - |
Filing Date Shares Outstanding | 0.71 | 0.13 | 0.03 | - | - | - |
Total Common Shares Outstanding | 0.42 | 0.06 | - | - | - | - |
Working Capital | -1.61 | 2.89 | 4.49 | 3.36 | 1.37 | 5.22 |
Book Value Per Share | -4.17 | 46.58 | - | - | - | - |
Tangible Book Value | -1.74 | 2.83 | -13 | 3.2 | 1.23 | 5.16 |
Tangible Book Value Per Share | -4.17 | 46.58 | - | - | - | - |
Machinery | - | - | - | - | - | 0.49 |